Central nervous system efficacy of furmonertinib versus gefitinib in patients with non–small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study.

Gongyan Chen, Yuankai Shi, Yunpeng Liu et al.|Journal of Clinical Oncology|2022

Cited by 5